Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-19, Stock:JNJ, The news for the past five days is as follows:
2021-11-12: NEWS1: General Electric, Tesla, Disney: Stocks That Defined the Week.NEWS2: One in three Americans aged 65 and above has got COVID-19 booster shot: CDC.NEWS3: Best way to minimize COVID-19 risk this holiday season is by getting vaccinated: Doctor.NEWS4: Why Johnson & Johnson Stock Rose Today.NEWS5: GE, J&J Breakups Add More Fuel to the Dealmaking Fire for Banks.NEWS6: Johnson & Johnson Pops As It Announces The Biggest Split In Health Care.NEWS7: Johnson & Johnson Plans to Split Into Two Companies.NEWS8: Moderna vaccine patent dispute: 'It’s a political story. It’s a financial story. It’s a legal story’.NEWS9: Johnson & Johnson Is Becoming Two Companies. What Happens to My Stock?.NEWS10: US STOCKS-Wall Street advances, powered by big tech.NEWS11: J&J’s Corporate Split: Just Another Big, Blue-Chip Breakup.NEWS12: J&J split will put spotlight on undervalued pipeline, CFO says.NEWS13: Coronavirus: Doctor sees ‘beginning of a wave’ as winter looms.NEWS14: Reactions to J&J's plans to split into two companies.NEWS15: Doctor's holiday gathering advice amid pandemic: 'Being vaccinated goes a long way'.NEWS16: QUOTEBOX-Reactions to J&J's plans to split into two companies.NEWS17: Johnson & Johnson (JNJ) Splitting Into Two Companies.NEWS18: Why Johnson & Johnson is splitting its drugs from its deodorants.NEWS19: US STOCKS-Wall Street powers higher on J&J, Big Tech boost.NEWS20: Johnson & Johnson Breakup Is No Clean Sweep.NEWS21: The Johnson & Johnson split ‘makes sense’ as it moves into ‘more innovative products’: Analyst.NEWS22: Factbox-J&J's legal liabilities as it plans to split.NEWS23: Stocks End Higher on Johnson & Johnson Spin-Off, Down for the Week.NEWS24: Johnson & Johnson Stock Is Gaining Because 2 Companies Might Make More Sense Than 1.NEWS25: Stock Market Rally Cools On Hot Inflation; Rivian IPO Revs Higher, Elon Musk Sells Tesla Shares; GE, J&J Plan Breakups: Weekly Review.NEWS26: Health-Care Giant J&J to Split Into Drug and Consumer Companies.NEWS27: Pre-Markets Edge Up on JNJ Split News.NEWS28: Four Big Takeaways From Johnson & Johnson’s Plans to Break Apart.NEWS29: Biden and Xi to meet virtually, AstraZeneca begins profiting off COVID vaccines, General Mills eyes sale of brands.NEWS30: Johnson & Johnson, with thousands of Philadelphia-area employees, to split into 2 companies.NEWS31: Dow Jones Leads As J&J Stock Rallies; Rivian IPO Revs Up, While Tesla Skids.NEWS32: US STOCKS-Wall Street rises on J&J, Big Tech boost.NEWS33: Johnson & Johnson Stock Rises on Plan for Breakup.NEWS34: Johnson & Johnson and Toshiba Just Followed GE’s Lead With Split Plans. Don’t Mourn the Conglomerate..NEWS35: Factbox-J&J's legal strategy for Baby Powder, talc liability.NEWS36: Factbox: Baby Powder to Band-Aid: Key facts on J&J's consumer health business.NEWS37: Johnson & Johnson CFO: Splitting company into two is about 'the potential unlocking of value for the consumer health business'.NEWS38: J&J Plans to Split in Two; Dow Up Triple Digits.NEWS39: Dow Jones Rallies As J&J Jumps On Breakup Plans; Tesla Falls, Rivian Races Higher.NEWS40: Johnson & Johnson  to split into two companies, consumer products and medical devices.NEWS41: Dow Jones Futures Rise As J&J Jumps On Breakup Plans; Rivian Set To Extend Rally.NEWS42: Johnson & Johnson Stock Jumps on Plan for Breakup.NEWS43: Johnson & Johnson To Spin Off Consumer Health Business: What You Need To Know.NEWS44: Johnson & Johnson to spin off consumer health unit from medical device and drug-making division.NEWS45: The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares.NEWS46: Wall Street rises on J&J, Big Tech boost.NEWS47: Pharma Stock Roundup: AZN, BAYRY Q3 Results, PFE COVID Pill's Strong Efficacy.NEWS48: Johnson & Johnson, Toshiba Follow GE With Split Plans. But the Conglomerate Is Far From Dead..NEWS49: J&J plans to split into two public companies and separate consumer and drug businesses.NEWS50: Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business.NEWS51: Healthcare giant Johnson & Johnson to split into two companies.NEWS52: Johnson & Johnson to split into two to focus on drugs.NEWS53: Johnson & Johnson Break-Up May Put Triple-A Credit Rating At Risk - Moody's.NEWS54: Premarket Movers Friday - Johnson & Johnson, Rivian, Nvidia.NEWS55: Johnson & Johnson Spin-Off Powers Dow Futures; Stocks Eye Bond Market Return Amid Inflation Jitters.NEWS56: J&J Pops on Decision to Split Consumer Health Business.NEWS57: Dow Futures Rise 110 Pts; Chinese Retail Giants, J&J in Focus.NEWS58: Johnson & Johnson Stock Leaps On Plan to Split Into Two Separate Companies.
2021-11-15: NEWS1: 9/11 Victim Fund Director Feinberg Is Named Mediator for J&J Fight.NEWS2: McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters.NEWS3: Vaccines sent to some of the 'hardest to reach' places with Zipline drone delivery.NEWS4: UPDATE 4-Washington state, in $95 billion opioid trial, blames drug distributors for crisis.NEWS5: J&J (JNJ) to Separate Consumer Unit Into New Company, Stock Up.NEWS6: Company News for Nov 15, 2021.NEWS7: Should You Buy Johnson & Johnson Before It Splits?.NEWS8: 10 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund.NEWS9: McKesson, drug distributors face $95 billion opioid trial in Washington state.NEWS10: Washington state seeks over $38 billion from opioid distributors.NEWS11: Will Johnson & Johnson’s Split Pay Off? History Says No..NEWS12: Johnson & Johnson Spinoff Plans Point to Rise of Direct to Consumer Commerce.
2021-11-16: NEWS1: U.S. administers 443.4 mln doses of COVID-19 vaccines - CDC.NEWS2: COVID-19 booster shots are 'going to be the norm,' NewYork-Presbyterian Hospital CEO explains.
2021-11-17: NEWS1: U.S. administers nearly 445 mln doses of COVID-19 vaccines - CDC.NEWS2: 'There will be another pandemic' and we need to be prepared when it comes: Doctor.NEWS3: Billionaire Ray Dalio: 'Misery and turbulence' ahead after inflation hits 31-year high — here are 3 shockproof stocks he's leaning on now.NEWS4: Stocks: Travel and crypto dip, retail rallies, pharmaceuticals rise.NEWS5: Inflation and Other News for Investors.NEWS6: Dividend Stock Portfolio: 10 Stock Picks by Hedge Funds.NEWS7: Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows.
2021-11-18: NEWS1: Covid has offered up 'acceptability and acceleration' of technologies like telemedicine: Janssen Head of R&D.NEWS2: Janssen head of R&D on Johnson & Johnson split.NEWS3: 10 Dividend Stocks in Warren Buffett’s Latest Portfolio.NEWS4: 'Everyone is a little bit confused' about COVID-19 vaccine mandates and rules: Doctor.NEWS5: FDA reviews mRNA booster shots for all adults ahead of holiday travel.NEWS6: Johnson & Johnson (JNJ) Down 0.3% Since Last Earnings Report: Can It Rebound?.NEWS7: Pharma Stock Roundup: JNJ to Spin Off Consumer Unit, PFE Eyes EUA for COVID Pill.NEWS8: J&J sees potential for 14 new multibillion-dollar drugs by 2025.NEWS9: 12 Best Big Stocks To Invest In.NEWS10: Why Conglomerates Split Up.

Answer: Rise